SIMEON Medical, one of the world's leading manufacturers of medical technology solutions for hospitals with focus on the OR, invests in a new, fully automated turning center.

The new production machine enables to produce all turned parts that are required to manufacture the products of the SIMEON portfolio directly at the company’s headquarter in Tuttlingen. These turned parts include, for example, individual components of the SIMEON operating and examination lights, as well as the Sim.MOVE 800 operating table that will be available soon.

With this investment, SIMEON is taking a further step towards autonomous production, regardless of supply chains and suppliers. By renewing the machinery, SIMEON also increases the level of automation in production. Overall, the investment aims to not only be able to act in the short term, but also to be able to plan in the long term, also with regard to the requirements of the new EU Medical Device Regulation (MDR).

The corona crisis and the associated economic turmoil in numerous industries confirmed managing director Tobias Lang in this strategic decision: “The corona pandemic has shown that dependence on international supply chains can quickly lead to problems in the event of a crisis. The more flexibly we can produce in-house, the more capable we remain. The general conditions of the MDR also play a major role here. 'Made in Germany' and especially 'Made in Tuttlingen' have always been and still are very important to us. This investment was also a decision to strengthen the production site and headquarter in Tuttlingen, ”said Lang.